Using computational biology to accelerate COVID-19 therapeutic development: Precision's
Renée Deehan, VP of Computational Biology, Quartz Bio, part of Precision for Medicine,
offers a proof of concept demonstrating the real-world utility of leveraging
biology approaches to streamline translational and clinical timelines. High Resolution
Modeling of COVID-19 Disease Biology.